PPMD — Protide Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Protide Pharmaceuticals, fiscal year end - August 31st, USD millions except per share, conversion factor applied.

	1999 August 31st	2000 August 31st	2001 August 31st	2002 August 31st	2003 August 31st
Period Length:	—	—	—	—	—
Source:	10KSB	10KSB	10KSB	10KSB	10KSB
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	0.53	0.625	0.412	0.282	0.202
Net Total Accounts Receivable
Net Total Receivables	0.03	0.041	0.026	0.037	0.046
Total Inventory
Total Other Current Assets
Total Current Assets	0.623	0.732	0.499	0.379	0.304
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.13	0.105	0.076	0.048	0.023
Net Intangible Assets
Total Assets	0.808	0.889	0.623	0.472	0.368
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.117	0.118	0.138	0.124	0.118
Total Long Term Debt
Total Debt
Total Liabilities	0.117	0.118	0.138	0.124	0.118
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	0.691	0.772	0.486	0.346	0.25
Total Liabilities & Shareholders' Equity	0.808	0.89	0.624	0.47	0.368
Total Common Shares Outstanding